Laser Treatment for Knee Osteoarthritis
Author Information
Author(s): Su Yu-Chi, Shen Yu-Ping, Chang Chih-Ya, Pan Ke-Ting, Huang Shih-Ming, Chen Liang-Cheng
Primary Institution: Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan
Hypothesis
ILIB therapy may decrease inflammation, mediate the inflammatory cascade, and further decrease pain and disability in patients with knee OA.
Conclusion
ILIB therapy significantly reduced knee OA pain and serum levels of certain inflammatory markers.
Supporting Evidence
- ILIB therapy showed significant improvement in WOMAC-pain scores at one month follow-up compared to the control group.
- IL-1β levels reduced significantly in the ILIB group at multiple follow-up points.
- IL-13 levels decreased significantly in the ILIB group compared to the control group.
Takeaway
This study tested a new laser treatment for knee pain and found it helped reduce pain and inflammation in patients.
Methodology
A double-blind randomized controlled trial with 17 knee OA patients assigned to ILIB and control groups, measuring pain and biomarkers at multiple time points.
Potential Biases
Potential placebo effect due to intravenous catheter placement in both groups.
Limitations
Small sample size and short follow-up duration; subjective outcome measurements.
Participant Demographics
Mean age of participants was 63 years, with a mix of genders.
Statistical Information
P-Value
p = 0.027
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website